These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 19215603

  • 1. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A, Itínere Project Group.
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [Abstract] [Full Text] [Related]

  • 2. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T, Project Itínere Working Group.
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [Abstract] [Full Text] [Related]

  • 3. [The prevalence of human immunodeficiency virus infection and the risk behaviors in the heroin addicts of Barcelona, Madrid and Seville: an example of the advantages of centering studies on addicts and not just on intravenous users].
    de la Fuente L, Bravo MJ, Lew C, Barrio G, Soriano V, Royuela L.
    Med Clin (Barc); 1999 Nov 20; 113(17):646-51. PubMed ID: 10618778
    [Abstract] [Full Text] [Related]

  • 4. Do supervised injecting facilities attract higher-risk injection drug users?
    Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.
    Am J Prev Med; 2005 Aug 20; 29(2):126-30. PubMed ID: 16005809
    [Abstract] [Full Text] [Related]

  • 5. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
    Morissette C, Cox J, De P, Tremblay C, Roy E, Allard R, Stephenson R, Graves L.
    Int J Drug Policy; 2007 May 20; 18(3):204-12. PubMed ID: 17689367
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.
    Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.
    Public Health; 2005 Dec 20; 119(12):1111-5. PubMed ID: 16214189
    [Abstract] [Full Text] [Related]

  • 7. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul 20; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

  • 8. Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain.
    Brugal MT, Pulido J, Toro C, de la Fuente L, Bravo MJ, Ballesta R, Soriano V, Barrio G, Vallejo F, Domingo-Salvany A, Castellano Y, Project Itinere Group.
    Eur Addict Res; 2009 Jul 20; 15(3):171-8. PubMed ID: 19506378
    [Abstract] [Full Text] [Related]

  • 9. Condom use among injection drug users accessing a supervised injecting facility.
    Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.
    Sex Transm Infect; 2009 Apr 20; 85(2):121-6. PubMed ID: 18812391
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville.
    Vallejo F, Toro C, de la Fuente L, Brugal MT, Soriano V, Silva TC, Bravo MJ, Ballesta R, Barrio G, Itinere Project Group.
    Eur Addict Res; 2008 Apr 20; 14(3):116-24. PubMed ID: 18552487
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A, Rajaleid K, Abel-Ollo K, Rüütel K, Rahu M, Rhodes T, Platt L, Bobrova N, Uusküla A.
    Int J Drug Policy; 2010 Jan 20; 21(1):56-63. PubMed ID: 19395249
    [Abstract] [Full Text] [Related]

  • 14. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
    Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T.
    J Public Health (Oxf); 2007 Mar 20; 29(1):35-9. PubMed ID: 17229788
    [Abstract] [Full Text] [Related]

  • 15. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY, Shah L, Jolly AM, Wylie JL.
    Addiction; 2007 Oct 20; 102(10):1626-35. PubMed ID: 17854339
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
    Spittal PM, Craib KJ, Wood E, Laliberté N, Li K, Tyndall MW, O'Shaughnessy MV, Schechter MT.
    CMAJ; 2002 Apr 02; 166(7):894-9. PubMed ID: 11949985
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors for hepatitis C among injecting drug users in Oslo].
    Dalgard O, Egeland A, Ervik R, Vilimas K, Skaug K, Steen TW.
    Tidsskr Nor Laegeforen; 2009 Jan 15; 129(2):101-4. PubMed ID: 19151801
    [Abstract] [Full Text] [Related]

  • 18. The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration.
    de la Fuente L, Barrio G, Royuela L, Bravo MJ.
    Addiction; 1997 Dec 15; 92(12):1749-63. PubMed ID: 9581007
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
    Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S.
    Sex Transm Infect; 2009 Apr 15; 85 Suppl 2():ii17-22. PubMed ID: 19307346
    [Abstract] [Full Text] [Related]

  • 20. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F, Barrio G, Brugal MT, Pulido J, Toro C, Sordo L, Espelt A, Bravo MJ, Itinere Project Group.
    J Epidemiol Community Health; 2015 Jun 15; 69(6):599-603. PubMed ID: 25870164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.